Military discontinues the use of jet
guns for mass immunization of military troops
U.S. Department of Defense (DoD)
needle-free injection policy chronology
(1997-11-20) Ped-O-Jet® manufacturer
(Keystone Industries, Cherry Hill, NJ) notifies
Defense Supply Center Philadelphia (DSCP)
(Defense Logistics Agency) of intent to withdraw as device supplier
over liability concern for bloodborne disease transmission from
multiple-use-nozzle design.
(1997-12-05) DoD
Medical Materiel Quality Control Program (MMQCP)
issues
withdrawal of automatic jet hypodermic injection
units (MMQC-97-1169).
(1997-12-07)
DSCP issues Medical Products Quality
Control System (MPQCS) device alert (DSCP 970147) as "cautionary
measure", while noting the absence of bloodborne disease transmission
case reports over 35 years of military use (followup
MMQC-98-1019 dated 1998-Jan-30).
(1998-01-09) Armed Forces
Epidemiological Board (AFEB) concurs with withdrawal of Ped-O-Jet® for
"routine immunization", but availability for "public health
emergency". AFEB recommends use of "newer technology" devices with
disposable parts for skin contact.
(1998-04-20)
Navy Bureau of Medicine and Surgery
updates via
BUMED notice 6230 its Immunization
Requirements And Recommendations document (3.6Mb .pdf)
prohibiting jet injector use until otherwise directed.
(1998-04-28) AFEB recommends DoD
formulate new needle-free injector specifications and support device
research and development.
(1998-07-09)
Letter from Dr. Sue Bailey, Assistant
Secretary of Defense, Health Affairs, to United States Representative
Alan B. Mollohan (D-WV), explaining DoD policy on jet injectors in
response to the concerns of a constituent of the Congressman.
(1998-1999) Manufacturer
discontinuation of large multi-dose vials
for yellow fever, meningococcal, and tetanus-diphtheria vaccines
because of military withdrawal of Ped-O-Jets® capable of using them (MMQC-99-1248
dated 1998-Nov-03 and
MMQC-99-1251 dated 1999-Aug-12).
(1998-11-25)
Navy Bureau of Medicine and Surgery authorizes
military use of new disposable-cartridge jet injector (Preventive
Medicine Directorate).
Current DoD policies
and information
available at the
Military Immunization Information Source
http://www.cdc.gov/nip/dev/jetinject.htm
(link no longer
active. This is a copy of .pdf file
2004 CDC Jetgun Bio Update )
Admission- Problems Existed With Jet
Injectors
NOVEMBER
1998
(((Thanks Roger))))
http://www-nehc.med.navy.mil/prevmed/epi/BUMED25NOV98.txt
SUBJ/MEDICAL JET INJECTOR USE FOR
IMMUNIZATIONS, UPDATE//
REF/A/DOC/BUMEDNOTE 6230/20APR98//
REF/B/MSG/NAVMEDLOGCOM FORT DETRICK
MD/081300ZDEC97/NOTAL//
NARR/REF A IS BUMED IMMUNIZATION
REQUIREMENTS AND
RECOMMENDATIONS NOTICE. REF B IS NAVMEDLOGCOM DRUG RECALL
NUMBER 97-75, DOD-MMQC-97-1169
AUTOMATIC JET
HYPODERMIC INJECTION UNITS/WITHDRAWAL
(DPSC 970147).//
POC/MCBRIDE/CDR,MC,USN/MED-24B/WASHINGTON DC/TEL:COM (202)762-3495
/TEL:DSN: 762-3495//
RMKS/1. THIS
MESSAGE HAS BEEN
COORDINATED WITH
THE COMMANDANT
OF THE MARINE
CORPS (CMC). THE
COMMANDANT HAS
AUTHORIZED
TRANSMISSION TO
MARINE CORPS
ACTIVITIES.
2. PURPOSE: UPDATE GUIDANCE IN REFS A AND B ON USING COMMERCIAL JET
INJECTORS FOR
ADMINISTERING
IMMUNIZATIONS.
3. BACKGROUND: SINCE ISSUING REFS A AND B, SEVERAL ACTIVITIES
EXPRESSED
INTEREST IN
USING A NEW
TRANSCUTANEOUS,
CO2 POWERED
IMMUNIZATION
DEVICE
MANUFACTURED BY
BIOJECT, INC.
THIS DEVICE,
MARKETED AS "BIOJECTOR
2000 INJECTION
MANAGEMENT
SYSTEM", IS THE
ONLY FOOD AND
DRUG
ADMINISTRATION
(FDA) LICENSED
HYPODERMIC JET
INJECTOR. IT
AVOIDS RISKS OF
BLOOD-BORNE
PATHOGEN
TRANSMISSION AND
NEEDLE-STICK
INJURY
ASSOCIATED WITH
PREVIOUSLY USED
JET INJECTOR
GUNS.
4. GUIDANCE:
A.
BIOJECTOR 2000
INJECTION
MANAGEMENT
SYSTEM IS
AUTHORIZED FOR
USE IN NAVY AND
MARINE CORPS
ACTIVITES FOR
IMMUNIZATION
ADMINISTRATION
TO SERVICE
MEMBERS AND
OTHER
BENEFICIARIES.
AT THIS TIME, NO
OTHER HYPODERMIC
JET INJECTOR
SYSTEM IS FDA
APPROVED-THIS IS
REQUIRED PRIOR
TO CONSIDERATION
FOR BUMED
AUTHORIZATION.
B. USE OF HYPODERMIC JET INJECTOR APPARATUS LISTED IN REF B
REMAINS
UNAUTHORIZED.
C. WITH BIOJECTOR 2000, ESTIMATED COST PER INJECTION AND
MECHANICS OF
PREPARATION FOR
EACH INJECTION
MAY LIMIT COST
AND PAGE 03
RUENMED3162
UNCLAS
EFFICIENCY
BENEFITS.
HOWEVER, THESE
CONCERNS MAY BE
OFFSET BY SAFETY
ENHANCEMENT
THROUGH
AVOIDANCE OF
BLOOD-BORNE
PATHOGEN
EXPOSURE AND
ELIMINATION OF
POSSIBLE
NEEDLE-STICK
INJURY TO
BOTH PATIENTS
AND THOSE
ADMINISTERING
IMMUNIZATIONS.
ALSO, SHARPS
DISPOSAL IS NOT
NECESSARY.
5. POINTS OF CONTACT:
A. PROCUREMENT: NAVMEDLOGCOM, FORT DETRICK,
MD-LT
WILLIAMS, TEL:
(301)619-3086;
DSN 343-3086 OR
HM1
SPICER,
TEL:
(301)619-7118;
DSN 343-7118.
B. BUMED-24: CDR
MCBRIDE, (AS
ABOVE)
EMAIL:
WZMCBRIDE@US.MED.NAVY.MIL.//
RTAUZYUW RUENMED3162
3291800-UUUU--RUCOFAE.
ZNR UUUUU
RUCKMEA T CG II
MEF
RUWICBD T
CG FIRST FSSG
RUWICBE T CG I
MEF
R 251800Z NOV 98 ZYB PSN 895734I36
FM BUMED WASHINGTON DC//24//
TO AIG SEVEN
SEVEN EIGHT
THREE
AIG SIX
NINE FOUR SEVEN
INFO AIG ONE
THREE SEVEN
SEVEN SIX
BT
UNCLAS
//N06230//
MSGID/GENADMIN/BUMED//